You can buy or sell KALV and other stocks, options, ETFs, and crypto commission-free!
KalVista Pharmaceuticals, Inc. Common Stock, also called KalVista Pharmaceuticals, is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Read More Its product candidates are inhibitors of plasma kallikrein being developed for two indications: hereditary angioedema (HAE) and diabetic macular edema (DME). The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
— per share
-$0.52 per share